A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Clinical trial NCT07431177 · RECRUITING
Trial details
- NCT number
- NCT07431177
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2028-06-06
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.